Belite Bio, Inc Debt Securities, Available-for-sale, Amortized Cost
Belite Bio, Inc (BLTE) had Debt Securities, Available-for-sale, Amortized Cost of $4.55 million as of 2024-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-03-31
- 2024-12-31: Debt Securities, Available-for-sale, Amortized Cost $4.55M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2024-12-31 | $4.55M 20-F · filed 2026-03-31 |